Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
100.00%
Operating Margin
68.02%
Net Margin
482.13%
Efficiency Metrics
Revenue per Expense Ratio
3.13
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
413.56%
Income Tax Rate
0.00%
EPS
$0.00
Balance Sheet Analysis
Current Ratio
18,724.0
Cash Ratio
0.21
Working Capital
$2.19M
Debt to Equity
0.00
Debt to Assets
0.07%
Equity Ratio
98.28%
Cash Flow Analysis
Operating Cash Flow Ratio
273.42%
Free Cash Flow Ratio
273.42%
CapEx to Revenue
0.00%
Dividends Paid
$47.20M
Stock Buybacks
$12.22M
Total Shareholder Returns
$59.42M
Cash Position Change
-89.30%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
118.52%
Net Income
189.23%
EPS
100.00%
Operating Income
0.00%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
1,636.06%
Operating Cash Flow
-8.23%
Free Cash Flow
-8.23%
Balance Sheet Health
Assets
6.43%
Debt
0.00%
Book Value per Share
-100.00%
Inventory
0.00%
Shareholder Returns
Dividends per Share
-100.00%
Shares Outstanding
-100.00%
Long Term Trends
3Y Revenue/Share
-100.00%
5Y Revenue/Share
-100.00%
3Y Dividend/Share
-100.00%
5Y Dividend/Share
-100.00%